Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1SHIRE PLC
03 7Takeda Pharmaceutical
01 1Concentrate For Infusion Solution
02 4Concentrate For Solution For Infusion
03 1INJ
04 1INJECTABLE; IV (INFUSION)
05 1Infusion Concentrate
06 1SOLUTION
01 1Allowed
02 1Approved
03 1Authorized
04 1Marketed
05 1Originator
06 2Prescription
07 1Schedule D
08 1Blank
01 2ELAPRASE
02 7Elaprase
01 1Canada
02 1Denmark
03 1Estonia
04 1Norway
05 1South Africa
06 1Spain
07 1Sweden
08 1Switzerland
09 1USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Elaprase
Dosage Form : INJ
Dosage Strength : 2mg/ml
Packaging : 3X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : USA
Brand Name : ELAPRASE
Dosage Form : INJECTABLE; IV (INFUSION)
Dosage Strength : 6MG/3ML
Packaging :
Approval Date :
Application Number : 125151
Regulatory Info :
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Elaprase
Dosage Form : Infusion Concentrate
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 20/03/2007
Application Number : 57916
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Elaprase
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Elaprase
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Elaprase
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 08-02-2007
Application Number : 6365001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : ELAPRASE
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 3ML
Approval Date :
Application Number : 2296314
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Elaprase
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 10-01-2007
Application Number : 28103881505
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Elaprase
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 08-01-2007
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
